A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

被引：0
|
作者：
Michael Willis
Knut Ödegaard
Ulf Persson
Johan Hedbrant
Dan Mellström
Mats Hammar
机构：
[1] IHE,The Swedish Institute for Health Economics
[2] University of Linköping,Systems Analysis Group
[3] Sahlgrenska University Hospital,Geriatric Clinic
[4] University Hospital,Obstetrics and Gynecology, Faculty of Health Sciences
来源：
Clinical Drug Investigation | 2001年 / 21卷
关键词：
Bone Mineral Density; Incremental Cost; Forearm Fracture; Osteoporotic Woman; Tibolone;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：115 / 127
页数：12
相关论文
共 50 条
  • [31] Prevention of osteoporotic fractures in Dutch men and women: A cost effectiveness evaluation
    De Laet, CE
    Pols, HAP
    [J]. BONE, 2001, 28 (05) : S93 - S93
  • [32] Modelled cost-effectiveness and cost-utility analysis of various treatment strategies in osteoporotic postmenopausal women in Poland
    Orlewska, E
    Lis, J
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 477 - 477
  • [33] Cost-effectiveness of alendronate in the treatment of postmenopausal women in the UK
    Borgström, F
    Johnell, O
    Jönsson, B
    Kanis, J
    Kong, SX
    Sen, SS
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S13 - S13
  • [34] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hansson-Hedblom, A.
    Geale, K.
    Borgstrom, F.
    Johansson, H.
    Fitzpatrick, L.
    Kanis, J. A.
    [J]. VALUE IN HEALTH, 2018, 21 : S197 - S197
  • [35] COST-EFFECTIVENESS OF ABALOPARATIDE FOR THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS
    Hiligsmann, M.
    Williams, S. A.
    Fitzpatrick, L. A.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S50 - S51
  • [36] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
    E. Söreskog
    I. Lindberg
    J.A. Kanis
    K.E. Åkesson
    D. Willems
    M. Lorentzon
    O. Ström
    P. Berling
    F. Borgström
    [J]. Osteoporosis International, 2021, 32 : 585 - 594
  • [37] Cost-effectiveness of romosozumab for the treatment of postmenopausal women with severe osteoporosis at high risk of fracture in Sweden
    Soreskog, E.
    Lindberg, I.
    Kanis, J. A.
    Akesson, K. E.
    Willems, D.
    Lorentzon, M.
    Strom, O.
    Berling, P.
    Borgstrom, F.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (03) : 585 - 594
  • [38] COST-EFFECTIVENESS OF DAIRY PRODUCTS SUPPLEMENTED WITH VITAMIN D IN THE PREVENTION OF OSTEOPOROTIC FRACTURES
    Ethgen, O.
    Hiligsmann, M.
    Bruyere, O.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S372 - S373
  • [39] NICE recommendations for the prevention of osteoporotic fractures in postmenopausal women
    Delmas, Pierre D.
    Siris, Ethel S.
    [J]. BONE, 2008, 42 (01) : 16 - 18
  • [40] COST-EFFECTIVENESS OF DENOSUMAB IN PREVENTING OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN FROM THE PRIVATE HEALTH CARE SETTING PERSPECTIVE IN BRAZIL
    Barbosa, E. G.
    Machado, M.
    Araujo, G. T. B. D.
    Etto, H.
    Fonseca, M.
    Olimpio, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A446 - A447
12345